You must log in to view this page.

You must log in to view this page.

Cullinan Therapeutics Inc.

NASDAQ: CGEM
Share price (8/15/25): $7.66
Market cap (8/15/25): $453 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Shelf registration

Registration of securities for employees

Shelf registration – amended

Ownership Filter

Lynx1 Capital Management LP

News Filter

Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Shareholder Vote Results

Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, From Genrix Bio for Development in Autoimmune Diseases

Provides Corporate Update and Reports First Quarter 2025 Financial Results

Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission